Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -89640.62% is 1089% below its 2-year average of -7541.13%, near the low end of its 2-year range (-89640.62%–57.26%).
521.07% below its 12-month average of -14433.16%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1255.91%.
EBITDA MARGIN
-89640.62%
EBITDA MARGIN AVG TTM
-14433.16%
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-521.07%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Connect Biopharma Holdings Limited
Market Cap
$56.43M
EBITDA Margin
-89640.62%
TTM Avg
-14433.16%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$54.90M
EBITDA Margin
-40.55%
TTM Avg
-30.41%
3Y Avg
-34.23%
5Y Avg
-32.87%
Market Cap
$58.77M
EBITDA Margin
-99843.01%
TTM Avg
-70984.01%
3Y Avg
-70984.01%
5Y Avg
-70984.01%
Market Cap
$53.63M
EBITDA Margin
-5927.25%
TTM Avg
-3470.39%
3Y Avg
-2050.54%
5Y Avg
-1465.25%
Market Cap
$59.76M
EBITDA Margin
-3226.05%
TTM Avg
-3226.05%
3Y Avg
-3226.05%
5Y Avg
-3226.05%
Market Cap
$60.43M
EBITDA Margin
-270.28%
TTM Avg
-442.93%
3Y Avg
-1031.00%
5Y Avg
-861.19%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Connect Biopharma Holdings Limited (CNTB) | $56.43M | -89640.62% | -14433.16% | N/A | N/A |
| Aldeyra The (ALDX)vs › | $56.71M | N/A | N/A | N/A | N/A |
| Boundless Bio, Inc. (BOLD)vs › | $57.20M | N/A | N/A | N/A | N/A |
| Spectral AI, Inc. (MDAI)vs › | $54.90M | -40.55% | -30.41% | -34.23% | -32.87% |
| Fractyl Health, Inc. (GUTS)vs › | $58.77M | -99843.01% | -70984.01% | -70984.01% | -70984.01% |
| ImageneBio Inc (IMA)vs › | $53.63M | -5927.25% | -3470.39% | -2050.54% | -1465.25% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $53.15M | N/A | N/A | N/A | N/A |
| MiNK Therapeutics, Inc. (INKT)vs › | $59.76M | -3226.05% | -3226.05% | -3226.05% | -3226.05% |
| Adicet Bio, Inc. (ACET)vs › | $60.43M | -270.28% | -442.93% | -1031.00% | -861.19% |
| eXoZymes, Inc. (EXOZ)vs › | $52.31M | N/A | N/A | N/A | N/A |
Gross Margin
100.0%
EBITDA Margin
-89640.6%
Operating Margin
-90740.6%
Net Margin
-86687.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -1255.91% |
| 2025-06-30 | -27610.42% |
| 2024-12-31 | -1355.44% |
| 2024-06-30 | 57.26% |
